287 related articles for article (PubMed ID: 17331719)
1. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
2. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
3. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
Lee HH; Wilson WR; Denny WA
Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxides.
Henderson ND; Plumb JA; Robins DJ; Workman P
Anticancer Drug Des; 1996 Sep; 11(6):421-38. PubMed ID: 8836108
[TBL] [Abstract][Full Text] [Related]
5. Unprecedented synthesis, in vitro and in vivo anti-cancer evaluation of novel triazolonaphthalimide derivatives.
Li S; Zhong W; Li Z; Meng X
Eur J Med Chem; 2012 Jan; 47(1):546-52. PubMed ID: 22138307
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new amonafide analogues via coupling reaction and their cytotoxic evaluation and DNA-binding studies.
Xie L; Xu Y; Wang F; Liu J; Qian X; Cui J
Bioorg Med Chem; 2009 Jan; 17(2):804-10. PubMed ID: 19070496
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity.
El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW
J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient antitumor agents of heterocycles containing sulfur atom: linear and angular thiazonaphthalimides against human lung cancer cell in vitro.
Qian X; Li Z; Yang Q
Bioorg Med Chem; 2007 Nov; 15(21):6846-51. PubMed ID: 17707644
[TBL] [Abstract][Full Text] [Related]
10. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
Wu A; Xu Y; Qian X
Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
[TBL] [Abstract][Full Text] [Related]
11. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths.
Wang K; Wang Y; Yan X; Chen H; Ma G; Zhang P; Li J; Li X; Zhang J
Bioorg Med Chem Lett; 2012 Jan; 22(2):937-41. PubMed ID: 22200595
[TBL] [Abstract][Full Text] [Related]
12. Antitumor studies. Part 4: Design, synthesis, antitumor activity, and molecular docking study of novel 2-substituted 2-deoxoflavin-5-oxides, 2-deoxoalloxazine-5-oxides, and their 5-deaza analogs.
Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Jan; 16(2):922-40. PubMed ID: 17962027
[TBL] [Abstract][Full Text] [Related]
13. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
[TBL] [Abstract][Full Text] [Related]
14. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
16. Antitumor studies. Part 1: design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents.
Ali HI; Tomita K; Akaho E; Kambara H; Miura S; Hayakawa H; Ashida N; Kawashima Y; Yamagishi T; Ikeya H; Yoneda F; Nagamatsu T
Bioorg Med Chem; 2007 Jan; 15(1):242-56. PubMed ID: 17049252
[TBL] [Abstract][Full Text] [Related]
17. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
18. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
Wu A; Xu Y; Qian X; Wang J; Liu J
Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Xia Q; Zhang L; Zhang J; Sheng R; Yang B; He Q; Hu Y
Eur J Med Chem; 2011 Mar; 46(3):919-26. PubMed ID: 21281992
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
